Table 1 Experiment design for mass test and treat (MTAT) with artemether-lumefantrine (AL)

Target ages receiving the campaign

All ages, children under 5, children 5–14, adults 25–49

Time between MTAT delivery rounds (total of three rounds)

2, 3, 4, 8 weeks

Proportion of the population reached per round by the MTAT campaign

0, 40, 72, 100 %

Proportion of the population who fully adhere to the AL drug regimen

50, 75, 100 %